Disease Surveillance and the Academic, Clinical, and Public Health Communities

The Emerging Infections Programs (EIPs), a population-based network involving 10 state health departments and the Centers for Disease Control and Prevention, complement and support local, regional, and national surveillance and research efforts. EIPs depend on collaboration between public health agencies and clinical and academic institutions to perform active, population-based surveillance for infectious diseases; conduct applied epidemiologic and laboratory research; implement and evaluate pilot prevention and intervention projects; and provide capacity for flexible public health response. Recent EIP work has included monitoring the impact of a new conjugate vaccine on the epidemiology of invasive pneumococcal disease, providing the evidence base used to derive new recommendations to prevent neonatal group B streptococcal disease, measuring the impact of foodborne diseases in the United States, and developing a systematic, integrated laboratory and epidemiologic method for syndrome-based surveillance.

[1]  A. Schuchat,et al.  Population-Based Surveillance in San Francisco and Atlanta Trends in Incidence and Antimicrobial Resistance of Early-Onset Sepsis: , 2005 .

[2]  Steven Black,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The Journal of pediatrics.

[3]  A. Schuchat,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.

[4]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[5]  K. O'Brien,et al.  Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. , 2002, Pediatrics.

[6]  L. Petersen,et al.  West Nile Virus: A Primer for the Clinician , 2002, Annals of Internal Medicine.

[7]  J. Hadler,et al.  A population-based estimate of the burden of diarrhoeal illness in the United States: FoodNet, 1996–7 , 2002, Epidemiology and Infection.

[8]  A. Schuchat,et al.  A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. , 2002, The New England journal of medicine.

[9]  Jeffrey P Koplan,et al.  Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. , 2002, JAMA.

[10]  R. M. Hendry,et al.  Surveillance for Unexplained Deaths and Critical Illnesses , 2002, Emerging infectious diseases.

[11]  K. O'Brien,et al.  Early-onset neonatal sepsis in the era of group B streptococcal prevention. , 2001, Pediatrics.

[12]  D. A. Dotson,et al.  Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. , 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  A. Schuchat,et al.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. , 2001, JAMA.

[14]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[15]  M. Cetron,et al.  Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.

[16]  Cynthia G. Whitney,et al.  Preventing pneumococcal disease among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2000 .

[17]  C. Glaser,et al.  Raccoon Roundworm (Baylisascaris procyonis) Encephalitis: Case Report and Field Investigation , 2000, Pediatrics.

[18]  A. Schuchat,et al.  Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. , 2000, Archives of internal medicine.

[19]  E. Fikrig,et al.  The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. , 2000, The Journal of infectious diseases.

[20]  N. Bean,et al.  Surveillance for foodborne-disease outbreaks--United States, 1993-1997. , 2000, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[21]  D. Asnis,et al.  The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[23]  D. Goldberg,et al.  Update: Clostridium novyi and unexplained illness among injecting-drug users--Scotland, Ireland, and England, April-June 2000. , 2000, MMWR. Morbidity and mortality weekly report.

[24]  J. Koplan.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[25]  J. Hadler,et al.  From the Centers for Disease Control and Prevention: early-onset group B streptococcal disease--United States, 1998-1999. , 2000, JAMA.

[26]  P. Cieslak,et al.  Preliminary FoodNet data on the incidence of foodborne illnesses--selected sites, United States, 1999. , 2000, MMWR. Morbidity and mortality weekly report.

[27]  C. Hedberg,et al.  Food-related illness and death in the United States. , 1999, Emerging infectious diseases.

[28]  A. Levitt,et al.  Preventing Emerging Infectious Diseases: A Strategy for the 21st Century. Overview of the Updated CDC plan. , 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[29]  R. Khabbaz,et al.  Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. , 1996, Archives of pathology & laboratory medicine.

[30]  R. Holman,et al.  Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. , 1996, Emerging infectious diseases.

[31]  M. Bardsley.  Surveillance for Creutzfeldt-Jakob disease--United States. , 1996, MMWR. Morbidity and mortality weekly report.

[32]  D. Th,et al.  Hantavirus pulmonary syndrome in New England and Europe. , 1994 .

[33]  R. Gaynes,et al.  Addressing emerging infectious disease threats; a prevention strategy for the United States : executive summary , 1994 .

[34]  Chief,et al.  Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary. , 1994, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[35]  A. Prince,et al.  Emerging Infections: Microbial Threats to Health in the United States , 1993 .

[36]  C. Baker.  Early onset group B streptococcal disease. , 1978, The Journal of pediatrics.

[37]  J. Duchin,et al.  Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized Disease , 1994 .